Kunkel Lori Anne Insider Trades

Insider Trading History

Track insider trading activity for Kunkel Lori Anne. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $2.54M 47,773 shares
Last Trade
Jul 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$505k 10,000 shares
$50.49
$53.16
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $2.88M 54,105 shares
Last Trade
Jun 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$345k 10,000 shares
$34.54
$53.16
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $910k 17,126 shares
Last Trade
Feb 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$465k 17,126 shares
$27.16
$53.16
ORIC Pharmaceuticals
ORIC Pharmaceuticals ORIC
Director
Holding Value $446k 40,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$327k 40,000 shares
$8.17
$11.14
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $1.63M 30,712 shares
Last Trade
Dec 17, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$256k 15,958 shares
$16.02
$53.16
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $199k 3,741 shares
Last Trade
Dec 17, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$256k 15,958 shares
$16.02
$53.16
ORIC Pharmaceuticals
ORIC Pharmaceuticals ORIC
Director
Holding Value $174k 15,600 shares
Last Trade
Dec 08, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$110k 10,000 shares
$11.00
$11.14
ORIC Pharmaceuticals
ORIC Pharmaceuticals ORIC
Director
Holding Value $938k 84,200 shares
Last Trade
Dec 08, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$110k 10,000 shares
$11.00
$11.14
ORIC Pharmaceuticals
ORIC Pharmaceuticals ORIC
Director
Holding Value $0 0 shares
Last Trade
Dec 04, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$63k 5,534 shares
$11.39
$11.14
ORIC Pharmaceuticals
ORIC Pharmaceuticals ORIC
Director
Holding Value $827k 74,200 shares
Last Trade
Dec 04, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$63k 5,534 shares
$11.39
$11.14
Nurix Therapeutics
Nurix Therapeutics NRIX
Director
Holding Value $596k 25,000 shares
Last Trade
May 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$238k 25,000 shares
$9.51
$23.85
ORIC Pharmaceuticals
ORIC Pharmaceuticals ORIC
Director
Holding Value $61.6k 5,534 shares
Last Trade
Mar 03, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$368k 48,166 shares
$7.64
$11.14
ORIC Pharmaceuticals
ORIC Pharmaceuticals ORIC
Director
Holding Value $765k 68,666 shares
Last Trade
Mar 03, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$368k 48,166 shares
$7.64
$11.14
Enliven Therapeutics
Enliven Therapeutics ELVN
Director
Holding Value $817k 15,368 shares
Last Trade
Feb 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$345k 15,368 shares
$22.47
$53.16
ORIC Pharmaceuticals
ORIC Pharmaceuticals ORIC
Director
Holding Value $390k 35,000 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$289k 35,000 shares
$8.26
$11.14
Nurix Therapeutics
Nurix Therapeutics NRIX
Director
Holding Value $0 0 shares
Last Trade
Jul 17, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$1.18M 54,027 shares
$21.77
$23.85
ORIC Pharmaceuticals
ORIC Pharmaceuticals ORIC
Director
Holding Value $285k 25,600 shares
Last Trade
Jun 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$202k 25,600 shares
$7.90
$11.14
ORIC Pharmaceuticals
ORIC Pharmaceuticals ORIC
Director
Holding Value $370k 33,200 shares
Last Trade
Jun 03, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$180k 20,500 shares
$8.78
$11.14
ORIC Pharmaceuticals
ORIC Pharmaceuticals ORIC
Director
Holding Value $228k 20,500 shares
Last Trade
Jun 03, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$180k 20,500 shares
$8.78
$11.14
Nurix Therapeutics
Nurix Therapeutics NRIX
Director
Holding Value $596k 25,000 shares
Last Trade
May 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$405k 25,000 shares
$16.19
$23.85

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up